Venkat is an experienced Biotech founder and builder with multiple companies under his belt. He brings years of knowledgeable experience as CEO, CSO specifically in immunology and oncology.  Additionally, he serves on the Boards of Tactile Therapeutics which he co-founded, Pharmacelera, and Tavira Therapeutics. Venkat brings a successful track record and extensive strategic and management experience, he has held senior executive roles in both European and US companies. Venkat has made significant contributions to the development of both small and large molecules in the fields of Oncology and Autoimmune diseases. He holds a MS in Biotechnology and a PhD from the Ludwig-Maximilians Universität München, where he specialized in immunology and oncology. Following his doctoral studies, Venkat undertook post-doctoral research at the renowned Scripps Research Institute also in Immunology and Oncology.